Search results for Alemtuzumab
Alemtuzumab Biosimilar – Anti-CD52 mAb – Research Grade, ProteoGenix, PX-TA1035
Description of Alemtuzumab Biosimilar - Anti-CD52 mAb - Research Grade General information on Anti-CD52(Homo sapiens) (Alemtuzumab) Monoclonal Antibody Alemtuzumab is a recombinant humanized monoclonal antibody (Campath-1H), which targets the 21-28 kD cell surface glycoprotein CD52. The Campath-1H antibody is of isotype IgG1, with human variable framework and constant regions, and a complementarity determining region derived from a murine (rat) monoclonal antibody (Campath-1G).
Host
Reactivity
Applications
Conjugation
Alemtuzumab, Affinityimmuno, ab-131-alemtuzumab
Host
Humanized
Reactivity
Applications
Conjugation
Alemtuzumab, Abbexa, abx831001
Alemtuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD52, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Alemtuzumab is a humanized monoclonal antibody against CD52, an antigen found on the surface of normal and malignant lymphocytes.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Alemtuzumab Biosimilar - Research Grade, ichor.bio, ICH4002
Detects human CD52. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Alemtuzumab.
Host
Humanized
Reactivity
Human
Applications
Conjugation
Research Grade Alemtuzumab (HB894016), abinScience, HB894016
Host
Humanized
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.